Skip to main content
Log in

Potentially inappropriate medication in acute hospitalized elderly patients with polypharmacy: an observational study comparing PRISCUS, STOPP, and Beers criteria

  • Pharmacoepidemiology and Prescription
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

A Correction to this article was published on 04 February 2021

This article has been updated

Abstract

Purpose

To compare the prevalence of potentially inappropriate medication (PIM) in the elderly according to the PRISCUS list, STOPP criteria, and Beers criteria. Secondary, to describe the differences using the three criteria focused on the inappropriate prescription of psychotropic drugs in the elderly.

Methods

A retrospective study was performed at Severo Ochoa University Hospital. The study included 365 patients, aged 80 years and older, living in Madrid, Spain.

Results

93.42% of patients received at least one PIM during hospitalization. Using the PRISCUS list, this changed from 32.6 to 2.7% at discharge. Applying STOPP criteria lowered the percentage from 65.20 to 10.95%, and with Beers criteria from 80.27 to 10.13. Lower Barthel index at admission was associated with an increased relative risk for receiving at least one PIM (OR 1.79, 95% CI 1.15–2.80, p = 0.024) using PRISCUS list as a tool in conjunction with STOPP criteria (OR 1.44, 95% CI 0.89–2.33, p = 0.037). Polypharmacy at admission predicted the presence of PIMs with STOPP criteria (OR 1.74, 95% CI 1.07–2.84, p = 0.001). Regarding psychotropic medicines, 208 patients (56.98%) received at least one psychotropic medicine during hospitalization. A total of 26.30% of patients were treated with psychotropic medicines, detected by the PRISCUS list, and 53.97% and 29.85% with STOPP and Beers, respectively.

Conclusions

Explicit criteria are a useful tool for identifying during hospitalization of the elderly patients. As indicated by the results, new research is needed to carry out an adaptation in our country that includes an evaluation of the strengths of the three tools to decrease PIMs and improve prescription in the elderly.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Data availability

The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

Change history

References

  1. WHO | 10 facts on ageing and the life course. https://www.who.int/features/factfiles/ageing/ageing_facts/en/index7.html. Accessed 28 Jan 2020

  2. INEbase/ Sociedad / Salud. https://www.ine.es/dyngs/INEbase/es/categoria.htm?c=Estadistica_P&cid=1254735573175. Accessed 4 Nov 2018

  3. Mangoni AA, Jackson SHD (2004) Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol 57:6–14. https://doi.org/10.1046/j.1365-2125.2003.02007.x

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Gonzalez-Colaço Harmand M, Aldea-Perona AM, Boada-Fernández del Campo C et al (2019) Spanish list of potentially inappropriate drugs in the elderly (ES-PIA project). Eur J Clin Pharmacol 75:1161–1176. https://doi.org/10.1007/s00228-019-02684-3

    Article  PubMed  Google Scholar 

  5. Mo L, Ding D, Pu S-Y et al (2016) Patients aged 80 years or older are encountered more potentially inappropriate medication use. Chin Med J (Engl) 129:22–27. https://doi.org/10.4103/0366-6999.172558

    Article  Google Scholar 

  6. Gutiérrez-Valencia M, Martínez-Velilla N, Vilches-Moraga A (2019) Polypharmacy in older people: time to take action. Eur Geriatr Med 10:1–3. https://doi.org/10.1007/s41999-018-0140-5

    Article  PubMed  Google Scholar 

  7. Miquel MDC, Cuervo MS, Silveira ED, et al (2010) Potentially inappropriate drug prescription in older subjects across health care settings. /data/revues/18787649/v1i1/S1878764910000033/

  8. Wickop B, Härterich S, Sommer C, Daubmann A, Baehr M, Langebrake C (2016) Potentially inappropriate medication use in multimorbid elderly inpatients: differences between the FORTA, PRISCUS and STOPP ratings. Drugs Real World Outcomes 3:317–325. https://doi.org/10.1007/s40801-016-0085-2

    Article  PubMed  PubMed Central  Google Scholar 

  9. Muhlack DC, Hoppe LK, Stock C, Haefeli WE, Brenner H, Schöttker B (2018) The associations of geriatric syndromes and other patient characteristics with the current and future use of potentially inappropriate medications in a large cohort study. Eur J Clin Pharmacol 74:1633–1644. https://doi.org/10.1007/s00228-018-2534-1

    Article  CAS  PubMed  Google Scholar 

  10. By the 2019 American Geriatrics Society Beers Criteria® Update Expert Panel (2019) American Geriatrics Society 2019 updated AGS Beers criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc 67:674–694. https://doi.org/10.1111/jgs.15767

    Article  Google Scholar 

  11. Holt S, Schmiedl S, Thürmann PA (2010) Potentially inappropriate medications in the elderly: the PRISCUS list. Dtsch Arztebl Int 107:543–551. https://doi.org/10.3238/arztebl.2010.0543

    Article  PubMed  PubMed Central  Google Scholar 

  12. O’Mahony D, O’Sullivan D, Byrne S et al (2015) STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing 44:213–218. https://doi.org/10.1093/ageing/afu145

    Article  PubMed  Google Scholar 

  13. Salbu RL, Feuer J (2017) A closer look at the 2015 Beers criteria. J Pharm Pract 30:419–424. https://doi.org/10.1177/0897190016663072

    Article  PubMed  Google Scholar 

  14. Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383

    Article  CAS  Google Scholar 

  15. González-Montalvo JI, Ramírez-Martín R, Menéndez Colino R et al (2019) Geriatría transversal. Un reto asistencial para el siglo xxi. Rev Esp Geriatría Gerontol S0211139X1930201X. https://doi.org/10.1016/j.regg.2019.10.011

  16. Siebert S, Elkeles B, Hempel G, Kruse J, Smollich M (2013) The PRISCUS list in clinical routine. Practicability and comparison to international PIM lists. Z Gerontol Geriatr 46:35–47. https://doi.org/10.1007/s00391-012-0324-4

    Article  CAS  PubMed  Google Scholar 

  17. Huang C-H, Umegaki H, Watanabe Y, Kamitani H, Asai A, Kanda S, Nomura H, Kuzuya M (2019) Potentially inappropriate medications according to STOPP-J criteria and risks of hospitalization and mortality in elderly patients receiving home-based medical services. PLoS One 14:e0211947. https://doi.org/10.1371/journal.pone.0211947

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Chang C-B, Lai H-Y, Yang S-Y, Wu RS, Liu HC, Hsu HY, Hwang SJ, Chan DC (2014) Patient- and clinic visit-related factors associated with potentially inappropriate medication use among older home healthcare service recipients. PLoS One 9:e94350. https://doi.org/10.1371/journal.pone.0094350

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Chiapella LC, Montemarani Menna J, Marzi M, Mamprin ME (2019) Prevalence of potentially inappropriate medications in older adults in Argentina using Beers criteria and the IFAsPIAM List. Int J Clin Pharm 41:913–919. https://doi.org/10.1007/s11096-019-00858-8

    Article  PubMed  Google Scholar 

  20. Galán Retamal C, Garrido Fernández R, Fernández Espínola S, Ruiz Serrato A, García Ordóñez MA, Padilla Marín V (2014) Prevalence of potentially inappropriate medication in hospitalized elderly patients by using explicit criteria. Farm Hosp 38:305–316. https://doi.org/10.7399/fh.2014.38.4.1148

  21. Blanco-Reina E, Valdellós J, Aguilar-Cano L, García-Merino MR, Ocaña-Riola R, Ariza-Zafra G, Bellido-Estévez I (2019) 2015 Beers criteria and STOPP v2 for detecting potentially inappropriate medication in community-dwelling older people: prevalence, profile, and risk factors. Eur J Clin Pharmacol 75:1459–1466. https://doi.org/10.1007/s00228-019-02722-0

  22. Mera F, Mestre D, Almeda J, Ferrer A, Formiga F, Rojas Farreras S, Grupo de Estudio Octabaix (2011) Paciente anciano y medicación crónica inapropiada en la comunidad ¿somos conscientes de ello? Rev Esp Geriatr Gerontol 46:125–130. https://doi.org/10.1016/j.regg.2010.12.008

  23. Gallagher P, Lang PO, Cherubini A, Topinková E, Cruz-Jentoft A, Montero Errasquín B, Mádlová P, Gasperini B, Baeyens H, Baeyens JP, Michel JP, O’Mahony D (2011) Prevalence of potentially inappropriate prescribing in an acutely ill population of older patients admitted to six European hospitals. Eur J Clin Pharmacol 67:1175–1188. https://doi.org/10.1007/s00228-011-1061-0

  24. Karandikar YS, Chaudhari SR, Dalal NP, Sharma M, Pandit VA (2013) Inappropriate prescribing in the elderly: a comparison of two validated screening tools. J Clin Gerontol Geriatr 4:109–114. https://doi.org/10.1016/j.jcgg.2013.04.004

  25. Henschel F, Redaelli M, Siegel M, Stock S (2015) Correlation of incident potentially inappropriate medication prescriptions and hospitalization: an analysis based on the PRISCUS list. Drugs Real World Outcomes 2:249–259. https://doi.org/10.1007/s40801-015-0035-4

  26. Roux B, Sirois C, Simard M et al (2019) Potentially inappropriate medications in older adults: a population-based cohort study. Fam Pract. https://doi.org/10.1093/fampra/cmz060

  27. Tommelein E, Mehuys E, Petrovic M, Somers A, Colin P, Boussery K (2015) Potentially inappropriate prescribing in community-dwelling older people across Europe: a systematic literature review. Eur J Clin Pharmacol 71:1415–1427. https://doi.org/10.1007/s00228-015-1954-4

  28. Denneboom W, Dautzenberg MG, Grol R, De Smet PA (2006) Analysis of polypharmacy in older patients in primary care using a multidisciplinary expert panel. Br J Gen Pract 56:504–510

  29. Romskaug R, Molden E, Straand J, Kersten H, Skovlund E, Pitkala KH, Wyller TB (2017) Cooperation between geriatricians and general practitioners for improved pharmacotherapy in home-dwelling elderly people receiving polypharmacy – the COOP study: study protocol for a cluster randomised controlled trial. Trials 18:158. https://doi.org/10.1186/s13063-017-1900-0

  30. Fromm MF, Maas R, Tümena T, Gaßmann K-G (2013) Potentially inappropriate medications in a large cohort of patients in geriatric units: association with clinical and functional characteristics. Eur J Clin Pharmacol 69:975–984. https://doi.org/10.1007/s00228-012-1425-0

  31. Hefner G, Stieffenhofer V, Gabriel S, Palmer G, Müller KM, Röschke J, Hiemke C (2015) Side effects related to potentially inappropriate medications in elderly psychiatric patients under everyday pharmacotherapy. Eur J Clin Pharmacol 71:165–172. https://doi.org/10.1007/s00228-014-1796-5

  32. Arnold I, Straube K, Himmel W, Heinemann S, Weiss V, Heyden L, Hummers-Pradier E, Nau R (2017) High prevalence of prescription of psychotropic drugs for older patients in a general hospital. BMC Pharmacol Toxicol 18:76. https://doi.org/10.1186/s40360-017-0183-0

  33. Ray WA, Chung CP, Murray KT, Hall K, Stein CM (2009) Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med 360:225–235. https://doi.org/10.1056/NEJMoa0806994

  34. Marston L, Nazareth I, Petersen I, Walters K, Osborn DP (2014) Prescribing of antipsychotics in UK primary care: a cohort study. BMJ Open 18;4(12):e006135. https://doi.org/10.1136/bmjopen-2014-006135

  35. Schubert I, Küpper-Nybelen J, Ihle P, Thürmann P (2013) Prescribing potentially inappropriate medication (PIM) in Germany’s elderly as indicated by the PRISCUS list. An analysis based on regional claims data. Pharmacoepidemiol Drug Saf 22:719–727. https://doi.org/10.1002/pds.3429

  36. Amann U, Schmedt N, Garbe E (2012) Prescribing of potentially inappropriate medications for the elderly: an analysis based on the PRISCUS list. Dtsch Arztebl Int 109:69–75. https://doi.org/10.3238/arztebl.2012.0069

  37. Vidal X, Agustí A, Vallano A et al (2016) Elderly patients treated with psychotropic medicines admitted to hospital: associated characteristics and inappropriate use. Eur J Clin Pharmacol 72:755–764. https://doi.org/10.1007/s00228-016-2032-2

Download references

Acknowledgments

We are indebted to Kelli White and Pilar Garcia del Vello for their expertise and invaluable advice in the English language.

Author information

Authors and Affiliations

Authors

Contributions

• Lorena de Agustín Sierra: Substantial contributions to the conception or design of the work, the acquisition, analysis, drafting the work or revising it critically for important intellectual content and interpretation of data for the work

• Jaime Rodríguez Salazar: Substantial contributions to the conception or design of the work, the acquisition, analysis, drafting the work or revising it critically for important intellectual content

• Ana Belén Jiménez-Muñoz: drafting the work or revising it critically for important intellectual content and final approval of the version to be published

• María Jesús Molina Hernández: drafting the work or revising it critically for important intellectual content and final approval of the version to be published

• Paloma Bermejo Bescós: Final approval of the version to be published

• Irene Iglesias Peinado: Final approval of the version to be published

• Benito García Díaz: Final approval of the version to be published

Corresponding author

Correspondence to Lorena de Agustín Sierra.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethics approval

The study has been approved by the Clinical Research Ethics Committee of Severo Ochoa University Hospital and is being conducted in accordance with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Consent to participate

For this type of study, formal consent is not required, since complete anonymity is maintained.

Consent to participate

The participant has consented to the submission of the original article to the journal.

Code availability

All data and materials as well as software application or custom code support their published claims and comply with field standards.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The original online version of this article was revised: Due to an error during production, some in-text and most of the bibliography list citations were not correctly displayed in the original previous online version of the article and have now been corrected.

Supplementary Information

ESM 1

(DOCX 109 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

de Agustín Sierra, L., Rodríguez Salazar, J., Jiménez-Muñoz, A.B. et al. Potentially inappropriate medication in acute hospitalized elderly patients with polypharmacy: an observational study comparing PRISCUS, STOPP, and Beers criteria. Eur J Clin Pharmacol 77, 757–766 (2021). https://doi.org/10.1007/s00228-020-03022-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-020-03022-8

Keywords

Navigation